APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicotinamide Mononucleotide (NMN)

Nicotinamide Mononucleotide (NMN) is a molecule naturally found in the body and is a precursor to nicotinamide adenine dinucleotide (NAD+), which plays a crucial role in various cellular processes. NAD+ is involved in energy metabolism, DNA repair, gene expression, and cell signaling.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Nicotinamide Mononucleotide (NMN) is a molecule naturally found in the body and is a precursor to nicotinamide adenine dinucleotide (NAD+), which plays a crucial role in various cellular processes. NAD+ is involved in energy metabolism, DNA repair, gene expression, and cell signaling.

NMN is considered a promising compound in anti-aging research due to its role in boosting NAD+ levels. As humans age, NAD+ levels tend to decline, which may contribute to age-related health issues. By supplementing with NMN, it's hypothesized that NAD+ levels can be replenished, potentially slowing down the aging process and improving overall health.

Selected research

Market Structure

Global Nicotinamide Mononucleotide (NMN) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025193 pages

Choose your research edition.

Industry ResearchNicotinamide Mononucleotide (NMN) Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicotinamide Mononucleotide (NMN) Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Nicotinamide Mononucleotide (NMN) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicotinamide Mononucleotide (NMN) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicotinamide Mononucleotide (NMN) Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

Nicotinamide Mononucleotide (NMN) is a molecule naturally found in the body and is a precursor to nicotinamide adenine dinucleotide (NAD+), which plays a crucial role in various cellular processes. NAD+ is involved in energy metabolism, DNA repair, gene expression, and cell signaling.

NMN is considered a promising compound in anti-aging research due to its role in boosting NAD+ levels. As humans age, NAD+ levels tend to decline, which may contribute to age-related health issues. By supplementing with NMN, it's hypothesized that NAD+ levels can be replenished, potentially slowing down the aging process and improving overall health.

The global Nicotinamide Mononucleotide (NMN) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

Read the full market overview

The US & Canada market for Nicotinamide Mononucleotide (NMN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nicotinamide Mononucleotide (NMN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Asia Pacific market for Nicotinamide Mononucleotide (NMN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Nicotinamide Mononucleotide (NMN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, MIRAILAB BIOSCIENCE Inc, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Nicotinamide Mononucleotide (NMN) output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Nicotinamide Mononucleotide (NMN) by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Nicotinamide Mononucleotide (NMN) market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nicotinamide Mononucleotide (NMN) and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nicotinamide Mononucleotide (NMN) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nicotinamide Mononucleotide (NMN) market size, projected growth trends, production technologies, key applications, and end-use industries.

Nicotinamide Mononucleotide (NMN) Segment by Company

GeneHarbor

Herbalmax

Genex Formulas

MIRAILAB BIOSCIENCE Inc

Maac10 Formulas

EffePharm

Bontac

CELFULL

Kingdomway

Oriental Yeast

Blue California (Conagen)

Borealis Pharma B.V. (Longevir®)

Nicotinamide Mononucleotide (NMN) Segment by Type

Content Greater than or Equal to 98%

Content Less than 98%

Nicotinamide Mononucleotide (NMN) Segment by Application

Health Care Products

Cosmetics

Others

Nicotinamide Mononucleotide (NMN) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Mononucleotide (NMN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Mononucleotide (NMN) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Mononucleotide (NMN).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nicotinamide Mononucleotide (NMN) market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nicotinamide Mononucleotide (NMN) industry.

Chapter 3: Detailed analysis of Nicotinamide Mononucleotide (NMN) market competition landscape. Including Nicotinamide Mononucleotide (NMN) manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Nicotinamide Mononucleotide (NMN) by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Nicotinamide Mononucleotide (NMN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Nicotinamide Mononucleotide (NMN) Industry Trends Table 2. Nicotinamide Mononucleotide (NMN) Industry Drivers Table 3. Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges Table 4. Nicotinamide Mononucleotide (NMN) Industry Restraints Table 5. Global Nicotinamide Mononucleotide (NMN) Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Nicotinamide Mononucleotide (NMN) Production Value Share by Manufacturers (2021-2026) Table 7. Global Nicotinamide Mononucleotide (NMN) Production by Manufacturers (Kg) & (2021-2026) Table 8. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers Table 9. Global Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg) of Manufacturers (2021-2026) Table 10. Global Nicotinamide Mononucleotide (NMN) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Nicotinamide Mononucleotide (NMN) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application Table 13. Global Nicotinamide Mononucleotide (NMN) Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Nicotinamide Mononucleotide (NMN) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Content Greater than or Equal to 98% Table 17. Major Manufacturers of Content Less than 98% Table 18. Global Nicotinamide Mononucleotide (NMN) Production by Type 2021 VS 2025 VS 2032 (Kg) Table 19. Global Nicotinamide Mononucleotide (NMN) Production by Type (2021-2026) & (Kg) Table 20. Global Nicotinamide Mononucleotide (NMN) Production by Type (2027-2032) & (Kg) Table 21. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2021-2026) Table 22. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2027-2032) Table 23. Global Nicotinamide Mononucleotide (NMN) Production Value by Type 2021 VS 2025 VS 2032 (Kg) Table 24. Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2021-2026) & (Kg) Table 25. Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2027-2032) & (Kg) Table 26. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2021-2026) Table 27. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2027-2032) Table 28. Major Manufacturers of Health Care Products Table 29. Major Manufacturers of Cosmetics Table 30. Major Manufacturers of Others Table 31. Global Nicotinamide Mononucleotide (NMN) Production by Application 2021 VS 2025 VS 2032 (Kg) Table 32. Global Nicotinamide Mononucleotide (NMN) Production by Application (2021-2026) & (Kg) Table 33. Global Nicotinamide Mononucleotide (NMN) Production by Application (2027-2032) & (Kg) Table 34. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2021-2026) Table 35. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2027-2032) Table 36. Global Nicotinamide Mononucleotide (NMN) Production Value by Application 2021 VS 2025 VS 2032 (Kg) Table 37. Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2021-2026) & (Kg) Table 38. Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2027-2032) & (Kg) Table 39. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2021-2026) Table 40. Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2027-2032) Table 41. GeneHarbor Company Information Table 42. GeneHarbor Business Overview Table 43. GeneHarbor Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 44. GeneHarbor Nicotinamide Mononucleotide (NMN) Product Portfolio Table 45. GeneHarbor Recent Development Table 46. Herbalmax Company Information Table 47. Herbalmax Business Overview Table 48. Herbalmax Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 49. Herbalmax Nicotinamide Mononucleotide (NMN) Product Portfolio Table 50. Herbalmax Recent Development Table 51. Genex Formulas Company Information Table 52. Genex Formulas Business Overview Table 53. Genex Formulas Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 54. Genex Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio Table 55. Genex Formulas Recent Development Table 56. MIRAILAB BIOSCIENCE Inc Company Information Table 57. MIRAILAB BIOSCIENCE Inc Business Overview Table 58. MIRAILAB BIOSCIENCE Inc Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 59. MIRAILAB BIOSCIENCE Inc Nicotinamide Mononucleotide (NMN) Product Portfolio Table 60. MIRAILAB BIOSCIENCE Inc Recent Development Table 61. Maac10 Formulas Company Information Table 62. Maac10 Formulas Business Overview Table 63. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 64. Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio Table 65. Maac10 Formulas Recent Development Table 66. EffePharm Company Information Table 67. EffePharm Business Overview Table 68. EffePharm Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 69. EffePharm Nicotinamide Mononucleotide (NMN) Product Portfolio Table 70. EffePharm Recent Development Table 71. Bontac Company Information Table 72. Bontac Business Overview Table 73. Bontac Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Bontac Nicotinamide Mononucleotide (NMN) Product Portfolio Table 75. Bontac Recent Development Table 76. CELFULL Company Information Table 77. CELFULL Business Overview Table 78. CELFULL Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. CELFULL Nicotinamide Mononucleotide (NMN) Product Portfolio Table 80. CELFULL Recent Development Table 81. Kingdomway Company Information Table 82. Kingdomway Business Overview Table 83. Kingdomway Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Kingdomway Nicotinamide Mononucleotide (NMN) Product Portfolio Table 85. Kingdomway Recent Development Table 86. Oriental Yeast Company Information Table 87. Oriental Yeast Business Overview Table 88. Oriental Yeast Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Oriental Yeast Nicotinamide Mononucleotide (NMN) Product Portfolio Table 90. Oriental Yeast Recent Development Table 91. Blue California (Conagen) Company Information Table 92. Blue California (Conagen) Business Overview Table 93. Blue California (Conagen) Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. Blue California (Conagen) Nicotinamide Mononucleotide (NMN) Product Portfolio Table 95. Blue California (Conagen) Recent Development Table 96. Borealis Pharma B.V. (Longevir®) Company Information Table 97. Borealis Pharma B.V. (Longevir®) Business Overview Table 98. Borealis Pharma B.V. (Longevir®) Nicotinamide Mononucleotide (NMN) Production (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. Borealis Pharma B.V. (Longevir®) Nicotinamide Mononucleotide (NMN) Product Portfolio Table 100. Borealis Pharma B.V. (Longevir®) Recent Development Table 101. Global Nicotinamide Mononucleotide (NMN) Production by Region: 2021 VS 2025 VS 2032 (Kg) Table 102. Global Nicotinamide Mononucleotide (NMN) Production by Region (2021-2026) & (Kg) Table 103. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2021-2026) Table 104. Global Nicotinamide Mononucleotide (NMN) Production Forecast by Region (2027-2032) & (Kg) Table 105. Global Nicotinamide Mononucleotide (NMN) Production Market Share Forecast by Region (2027-2032) Table 106. Global Nicotinamide Mononucleotide (NMN) Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 107. Global Nicotinamide Mononucleotide (NMN) Production Value by Region (2021-2026) & (US$ Million) Table 108. Global Nicotinamide Mononucleotide (NMN) Production Value Share by Region (2021-2026) Table 109. Global Nicotinamide Mononucleotide (NMN) Production Value by Region (2027-2032) & (US$ Million) Table 110. Global Nicotinamide Mononucleotide (NMN) Production Value Share by Region: (2027-2032) & (US$ Million) Table 111. Global Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2021-2026) Table 112. Global Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2027-2032) Table 113. Global Nicotinamide Mononucleotide (NMN) Consumption by Region: 2021 VS 2025 VS 2032 (Kg) Table 114. Global Nicotinamide Mononucleotide (NMN) Consumption by Region (2021-2026) & (Kg) Table 115. Global Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region (2021-2026) Table 116. Global Nicotinamide Mononucleotide (NMN) Consumption Forecasted by Region (2027-2032) & (Kg) Table 117. Global Nicotinamide Mononucleotide (NMN) Consumption Forecasted Market Share by Region (2027-2032) Table 118. North America Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 119. North America Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2026) & (Kg) Table 120. North America Nicotinamide Mononucleotide (NMN) Consumption by Country (2027-2032) & (Kg) Table 121. Europe Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 122. Europe Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2026) & (Kg) Table 123. Europe Nicotinamide Mononucleotide (NMN) Consumption by Country (2027-2032) & (Kg) Table 124. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 125. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2026) & (Kg) Table 126. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption by Country (2027-2032) & (Kg) Table 127. South America Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 128. South America Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2026) & (Kg) Table 129. South America Nicotinamide Mononucleotide (NMN) Consumption by Country (2027-2032) & (Kg) Table 130. Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Kg) Table 131. Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2026) & (Kg) Table 132. Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption by Country (2027-2032) & (Kg) Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Nicotinamide Mononucleotide (NMN) Distributors List Table 136. Nicotinamide Mononucleotide (NMN) Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Nicotinamide Mononucleotide (NMN) Product Image Figure 2. Global Nicotinamide Mononucleotide (NMN) Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotinamide Mononucleotide (NMN) Production Value (2021-2032) & (US$ Million) Figure 4. Global Nicotinamide Mononucleotide (NMN) Production Capacity (2021-2032) & (Kg) Figure 5. Global Nicotinamide Mononucleotide (NMN) Production (2021-2032) & (Kg) Figure 6. Global Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg) & (2021-2032) Figure 7. Global Top 5 and 10 Nicotinamide Mononucleotide (NMN) Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Content Greater than or Equal to 98% Image Figure 10. Content Less than 98% Image Figure 11. Global Nicotinamide Mononucleotide (NMN) Production by Type (2021 VS 2025 VS 2032) & (Kg) Figure 12. Global Nicotinamide Mononucleotide (NMN) Production Market Share 2021 VS 2025 VS 2032 Figure 13. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2021-2032) Figure 14. Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2021 VS 2025 VS 2032) & (Kg) Figure 15. Global Nicotinamide Mononucleotide (NMN) Production Value Share 2021 VS 2025 VS 2032 Figure 16. Global Nicotinamide Mononucleotide (NMN) Production Value Share by Type (2021-2032) Figure 17. Health Care Products Image Figure 18. Cosmetics Image Figure 19. Others Image Figure 20. Global Nicotinamide Mononucleotide (NMN) Production by Application (2021 VS 2025 VS 2032) & (Kg) Figure 21. Global Nicotinamide Mononucleotide (NMN) Production Market Share 2021 VS 2025 VS 2032 Figure 22. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2021-2032) Figure 23. Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2021 VS 2025 VS 2032) & (Kg) Figure 24. Global Nicotinamide Mononucleotide (NMN) Production Value Share 2021 VS 2025 VS 2032 Figure 25. Global Nicotinamide Mononucleotide (NMN) Production Value Share by Application (2021-2032) Figure 26. Global Nicotinamide Mononucleotide (NMN) Production by Region: 2021 VS 2025 VS 2032 (Kg) Figure 27. Global Nicotinamide Mononucleotide (NMN) Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Nicotinamide Mononucleotide (NMN) Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Nicotinamide Mononucleotide (NMN) Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Nicotinamide Mononucleotide (NMN) Production Value (2021-2032) & (US$ Million) Figure 31. Europe Nicotinamide Mononucleotide (NMN) Production Value (2021-2032) & (US$ Million) Figure 32. Asia-Pacific Nicotinamide Mononucleotide (NMN) Production Value (2021-2032) & (US$ Million) Figure 33. South America Nicotinamide Mononucleotide (NMN) Production Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Nicotinamide Mononucleotide (NMN) Production Value (2021-2032) & (US$ Million) Figure 35. North America Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 36. North America Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021-2032) Figure 37. U.S. Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 38. Canada Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 39. Mexico Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 40. Europe Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 41. Europe Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021-2032) Figure 42. Germany Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 43. France Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 44. U.K. Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 45. Italy Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 46. Netherlands Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 47. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 48. Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021-2032) Figure 49. China Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 50. Japan Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 51. South Korea Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 52. Southeast Asia Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 53. India Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 54. Australia Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 55. South America Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 56. South America Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021-2032) Figure 57. Brazil Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 58. Argentina Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 59. Chile Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 60. Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 61. Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2021-2032) Figure 62. Egypt Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 63. South Africa Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 64. Israel Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 65. Türkiye Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 66. GCC Countries Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2021-2032) & (Kg) Figure 67. Nicotinamide Mononucleotide (NMN) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Nicotinamide Mononucleotide (NMN) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Content Greater than or Equal to 98%
  • Content Less than 98%
Applications
  • Health Care Products
  • Cosmetics
  • Others
Companies covered
  • GeneHarbor
  • Herbalmax
  • Genex Formulas
  • MIRAILAB BIOSCIENCE Inc
  • Maac10 Formulas
  • EffePharm
  • Bontac
  • CELFULL
  • Kingdomway
  • Oriental Yeast
  • Blue California (Conagen)
  • Borealis Pharma B.V. (Longevir®)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nicotinamide Mononucleotide (NMN) Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Nicotinamide Mononucleotide (NMN) Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Nicotinamide Mononucleotide (NMN) Market Dynamics
  1. 2.1 Nicotinamide Mononucleotide (NMN) Industry Trends
  2. 2.2 Nicotinamide Mononucleotide (NMN) Industry Drivers
  3. 2.3 Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges
  4. 2.4 Nicotinamide Mononucleotide (NMN) Industry Restraints
3 Nicotinamide Mononucleotide (NMN) Market by Manufacturers
  1. 3.1 Global Nicotinamide Mononucleotide (NMN) Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Nicotinamide Mononucleotide (NMN) Production by Manufacturers (2021-2026)
  3. 3.3 Global Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Nicotinamide Mononucleotide (NMN) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nicotinamide Mononucleotide (NMN) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application
  7. 3.7 Global Nicotinamide Mononucleotide (NMN) Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nicotinamide Mononucleotide (NMN) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nicotinamide Mononucleotide (NMN) Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Nicotinamide Mononucleotide (NMN) Tier 1, Tier 2, and Tier 3
4 Nicotinamide Mononucleotide (NMN) Market by Type
  1. 4.1 Nicotinamide Mononucleotide (NMN) Type Introduction
  2. 4.1.1 Content Greater than or Equal to 98%
  3. 4.1.2 Content Less than 98%
  4. 4.2 Global Nicotinamide Mononucleotide (NMN) Production by Type
  5. 4.2.1 Global Nicotinamide Mononucleotide (NMN) Production by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nicotinamide Mononucleotide (NMN) Production by Type (2021-2032)
  7. 4.2.3 Global Nicotinamide Mononucleotide (NMN) Production Market Share by Type (2021-2032)
  8. 4.3 Global Nicotinamide Mononucleotide (NMN) Production Value by Type
  9. 4.3.1 Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nicotinamide Mononucleotide (NMN) Production Value by Type (2021-2032)
  11. 4.3.3 Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Type (2021-2032)
5 Nicotinamide Mononucleotide (NMN) Market by Application
  1. 5.1 Nicotinamide Mononucleotide (NMN) Application Introduction
  2. 5.1.1 Health Care Products
  3. 5.1.2 Cosmetics
  4. 5.1.3 Others
  5. 5.2 Global Nicotinamide Mononucleotide (NMN) Production by Application
  6. 5.2.1 Global Nicotinamide Mononucleotide (NMN) Production by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nicotinamide Mononucleotide (NMN) Production by Application (2021-2032)
  8. 5.2.3 Global Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2021-2032)
  9. 5.3 Global Nicotinamide Mononucleotide (NMN) Production Value by Application
  10. 5.3.1 Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Nicotinamide Mononucleotide (NMN) Production Value by Application (2021-2032)
  12. 5.3.3 Global Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 GeneHarbor
  2. 6.1.1 GeneHarbor Company Information
  3. 6.1.2 GeneHarbor Business Overview
  4. 6.1.3 GeneHarbor Nicotinamide Mononucleotide (NMN) Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 GeneHarbor Nicotinamide Mononucleotide (NMN) Product Portfolio
  6. 6.1.5 GeneHarbor Recent Developments
  7. 6.2 Herbalmax
  8. 6.2.1 Herbalmax Company Information
  9. 6.2.2 Herbalmax Business Overview
  10. 6.2.3 Herbalmax Nicotinamide Mononucleotide (NMN) Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Herbalmax Nicotinamide Mononucleotide (NMN) Product Portfolio
  12. 6.2.5 Herbalmax Recent Developments
  13. 6.3 Genex Formulas
  14. 6.3.1 Genex Formulas Company Information
  15. 6.3.2 Genex Formulas Business Overview
  16. 6.3.3 Genex Formulas Nicotinamide Mononucleotide (NMN) Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Genex Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio
  18. 6.3.5 Genex Formulas Recent Developments
  19. 6.4 MIRAILAB BIOSCIENCE Inc
  20. 6.4.1 MIRAILAB BIOSCIENCE Inc Company Information
  21. 6.4.2 MIRAILAB BIOSCIENCE Inc Business Overview
  22. 6.4.3 MIRAILAB BIOSCIENCE Inc Nicotinamide Mononucleotide (NMN) Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 MIRAILAB BIOSCIENCE Inc Nicotinamide Mononucleotide (NMN) Product Portfolio
  24. 6.4.5 MIRAILAB BIOSCIENCE Inc Recent Developments
  25. 6.5 Maac10 Formulas
  26. 6.5.1 Maac10 Formulas Company Information
  27. 6.5.2 Maac10 Formulas Business Overview
  28. 6.5.3 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Maac10 Formulas Nicotinamide Mononucleotide (NMN) Product Portfolio
  30. 6.5.5 Maac10 Formulas Recent Developments
  31. 6.6 EffePharm
  32. 6.6.1 EffePharm Company Information
  33. 6.6.2 EffePharm Business Overview
  34. 6.6.3 EffePharm Nicotinamide Mononucleotide (NMN) Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 EffePharm Nicotinamide Mononucleotide (NMN) Product Portfolio
  36. 6.6.5 EffePharm Recent Developments
  37. 6.7 Bontac
  38. 6.7.1 Bontac Company Information
  39. 6.7.2 Bontac Business Overview
  40. 6.7.3 Bontac Nicotinamide Mononucleotide (NMN) Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Bontac Nicotinamide Mononucleotide (NMN) Product Portfolio
  42. 6.7.5 Bontac Recent Developments
  43. 6.8 CELFULL
  44. 6.8.1 CELFULL Company Information
  45. 6.8.2 CELFULL Business Overview
  46. 6.8.3 CELFULL Nicotinamide Mononucleotide (NMN) Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 CELFULL Nicotinamide Mononucleotide (NMN) Product Portfolio
  48. 6.8.5 CELFULL Recent Developments
  49. 6.9 Kingdomway
  50. 6.9.1 Kingdomway Company Information
  51. 6.9.2 Kingdomway Business Overview
  52. 6.9.3 Kingdomway Nicotinamide Mononucleotide (NMN) Production, Value and Gross Margin (2021-2026)
  53. 6.9.4 Kingdomway Nicotinamide Mononucleotide (NMN) Product Portfolio
  54. 6.9.5 Kingdomway Recent Developments
  55. 6.10 Oriental Yeast
  56. 6.10.1 Oriental Yeast Company Information
  57. 6.10.2 Oriental Yeast Business Overview
  58. 6.10.3 Oriental Yeast Nicotinamide Mononucleotide (NMN) Production, Value and Gross Margin (2021-2026)
  59. 6.10.4 Oriental Yeast Nicotinamide Mononucleotide (NMN) Product Portfolio
  60. 6.10.5 Oriental Yeast Recent Developments
  61. 6.11 Blue California (Conagen)
  62. 6.11.1 Blue California (Conagen) Company Information
  63. 6.11.2 Blue California (Conagen) Business Overview
  64. 6.11.3 Blue California (Conagen) Nicotinamide Mononucleotide (NMN) Production, Value and Gross Margin (2021-2026)
  65. 6.11.4 Blue California (Conagen) Nicotinamide Mononucleotide (NMN) Product Portfolio
  66. 6.11.5 Blue California (Conagen) Recent Developments
  67. 6.12 Borealis Pharma B.V. (Longevir®)
  68. 6.12.1 Borealis Pharma B.V. (Longevir®) Company Information
  69. 6.12.2 Borealis Pharma B.V. (Longevir®) Business Overview
  70. 6.12.3 Borealis Pharma B.V. (Longevir®) Nicotinamide Mononucleotide (NMN) Production, Value and Gross Margin (2021-2026)
  71. 6.12.4 Borealis Pharma B.V. (Longevir®) Nicotinamide Mononucleotide (NMN) Product Portfolio
  72. 6.12.5 Borealis Pharma B.V. (Longevir®) Recent Developments
7 Global Nicotinamide Mononucleotide (NMN) Production by Region
  1. 7.1 Global Nicotinamide Mononucleotide (NMN) Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Nicotinamide Mononucleotide (NMN) Production by Region (2021-2032)
  3. 7.2.1 Global Nicotinamide Mononucleotide (NMN) Production by Region (2021-2026)
  4. 7.2.2 Global Nicotinamide Mononucleotide (NMN) Production Forecast by Region (2027-2032)
  5. 7.3 Global Nicotinamide Mononucleotide (NMN) Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Nicotinamide Mononucleotide (NMN) Production Value by Region (2021-2032)
  7. 7.4.1 Global Nicotinamide Mononucleotide (NMN) Production Value by Region (2021-2026)
  8. 7.4.2 Global Nicotinamide Mononucleotide (NMN) Production Value by Region (2027-2032)
  9. 7.5 Global Nicotinamide Mononucleotide (NMN) Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Nicotinamide Mononucleotide (NMN) Production Value (2021-2032)
  12. 7.6.2 Europe Nicotinamide Mononucleotide (NMN) Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Nicotinamide Mononucleotide (NMN) Production Value (2021-2032)
  14. 7.6.4 South America Nicotinamide Mononucleotide (NMN) Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Nicotinamide Mononucleotide (NMN) Production Value (2021-2032)
8 Global Nicotinamide Mononucleotide (NMN) Consumption by Region
  1. 8.1 Global Nicotinamide Mononucleotide (NMN) Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Nicotinamide Mononucleotide (NMN) Consumption by Region (2021-2032)
  3. 8.2.1 Global Nicotinamide Mononucleotide (NMN) Consumption by Region (2021-2026)
  4. 8.2.2 Global Nicotinamide Mononucleotide (NMN) Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Nicotinamide Mononucleotide (NMN) Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nicotinamide Mononucleotide (NMN) Value Chain Analysis
  2. 9.1.1 Nicotinamide Mononucleotide (NMN) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nicotinamide Mononucleotide (NMN) Production Mode & Process
  6. 9.2 Nicotinamide Mononucleotide (NMN) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nicotinamide Mononucleotide (NMN) Distributors
  9. 9.2.3 Nicotinamide Mononucleotide (NMN) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst